Glaxo To Pay $40M For Faulty Medications

June 23, 2011

Rachel Zimmerman

The British drug giant agrees to a settlement for selling substandard antidepressants, among other medicines

British drugmaker GlaxoSmithKline PLC will pay $40.75 million to 37 states and the District of Columbia for selling substandard antidepressants and other medicines produced at its former Puerto Rico factory.
The states and the District of Columbia filed complaints against the company under their consumer protection laws following a $750 million settlement with the federal government last October.
Both settlements involve production of adulterated, or substandard, products made from 2001 through 2005 at a factory in Cidra, Puerto Rico. Those included antidepressant Paxil CR, anti-infection ointment Bactroban, sterile anti-nausea medication Kytril and combination Type 2 diabetes pill Avandamet.
GSK admits no wrongdoing.

This program aired on June 23, 2011. The audio for this program is not available.

Medicine Money